Swahili
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

white/kunona

Kiungo kimehifadhiwa kwenye clipboard
14 matokeo

Compositions and methods for white to beige adipogenesis

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD This disclosure relates to compositions for white to beige adipogenesis and methods of using the same, which may be used to treat or prevent obesity. INTRODUCTION Obesity and its associated disorders are common and very serious public health problems in the United States and throughout the

Compounds and methods for inducing browning of white adipose tissue

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF INVENTION The present invention relates to a compound for inducing browning of white adipose tissue in vitro and in vivo, the preparation method thereof, as well as a composition comprising the same. Further, the present invention relates to the use of the compound and the method to treat

Composition for treating obesity comprising extract from white kidney beans, red kidney beans, and green tea leaves

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF INVENTION This invention relates to the field of treating obesity, associated metabolic and physical aberrations such as altered plasma lipid profile and elevated blood pressure. BACKGROUND Obesity is rapidly becoming a major health problem in modern society. It is increasing in prevalence
This application is a national phase application under 35 U.S.C. .sctn. 371 of International Application No. PCT/EP2015/053165, filed Feb. 13, 2015, which claims priority to European Application No. 14155088.9, filed Feb. 13, 2014, the entire contents of each of which are incorporated herein by

Mito-Ob: a transgenic mouse model for obesity

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION Obesity is a significant health problem. Obesity has reached epidemic proportions globally, and the World Health Organization estimates that there are more than 1 billion overweight adults (BMI of 25.0-29.9), of which at least 300 million are obese (BMI of 30 or above)

Method for treating, managing, inhibiting, or preventing obesity

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND 1. Field of the Invention The present invention relates to a composition for inducing brown adipocytes and inducing differentiation into beige adipocytes from white adipocytes, the composition including butein, a butein derivative or a pharmaceutically available salt thereof as an active

Injectable brown adipose microtissues for treatment and prevention of obesity and diabetes

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND During the past 20 years, there has been a dramatic increase in obesity in the United States and these rates remain high. In 2010, no state had a prevalence of obesity less than 20%. Not only does obesity threaten a significant portion of the United States population, but this health

Materials and methods for the treatment or prevention of obesity

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION The regulation of body weight, and particularly body fat, in animals is a complex process having enormous implications for the health and well being of humans and other animals. Excess body weight and/or an excess of body fat relative to lean body mass has been associated

Materials and methods for the treatment or prevention of obesity

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION The regulation of body weight, and particularly body fat, in animals is a complex process having enormous implications for the health and well being of humans and other animals. Excess body weight and/or an excess of body fat relative to lean body mass has been associated

Pre-adipose cell lines

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND ART This invention relates to human pre-adipose cell lines capable to differentiate into adipose cells. In particular, the present invention pertains to pre-adipose cell lines derived from white adipose tissue and their use in developing drugs, food ingredients and supplements against

Human and rat PGC-3, PPAR-gamma coactivations and splice variants thereof

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
This application is a national stage filing under 35 U.S.C. 371 of International Application No. PCT/GB01/04074, filed Sep. 12, 2001, which claims priority from United Kingdom Application No. 0022670.4, filed Sep. 15, 2000, the specifications of each of which are incorporated by reference herein.

Composition for inducing differentiation into beige and brown adipocytes and method of inducing the same

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
CROSS-REFERENCE TO RELATED APPLICATION This application claims priority to and the benefit of Korean Patent Application No. 10-2014-0078275, filed on Jun. 25, 2014, and 10-2015-0071581, filed on May 22, 2015, the disclosure of which is incorporated herein by reference in its entirety. SEQUENCE

Nuclear receptor binding agents

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
FIELD OF THE INVENTION The present invention relates to methods for prevention and/or treatment of metabolic disorders, post-menopausal obesity and conditions associated with high fat diet consumption including, obesity, body weight gain, fat mass formation, bone mineral content reduction, white

Method of using abscisic acid to treat diseases and disorders

Watumiaji waliosajiliwa tu ndio wanaweza kutafsiri nakala
Ingia / Ingia
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the field of medical treatments for diseases and disorders. More specifically, the present invention relates to biologically active compounds that treat and prevent insulin resistance, impaired glucose tolerance,
Jiunge na ukurasa
wetu wa facebook

Hifadhidata kamili ya mimea ya dawa inayoungwa mkono na sayansi

  • Inafanya kazi katika lugha 55
  • Uponyaji wa mitishamba unaungwa mkono na sayansi
  • Kutambua mimea kwa picha
  • Ramani ya GPS inayoshirikiana
  • Soma machapisho ya kisayansi yanayohusiana na utafutaji wako
  • Tafuta mimea ya dawa na athari zao
  • Panga maslahi yako na fanya tarehe ya utafiti wa habari, majaribio ya kliniki na ruhusu

Andika dalili au ugonjwa na usome juu ya mimea ambayo inaweza kusaidia, chapa mimea na uone magonjwa na dalili ambazo hutumiwa dhidi yake.
* Habari zote zinategemea utafiti wa kisayansi uliochapishwa

Google Play badgeApp Store badge